BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lisco A, Wong CS, Price S, Ye P, Niemela J, Anderson M, Richards E, Manion M, Mystakelis H, Similuk M, Lo B, Stoddard J, Rosenzweig S, Vanpouille C, Rupert A, Maric I, Perez-Diez A, Parenti D, Burbelo PD, Rao VK, Sereti I. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS). Front Immunol 2019;10:1193. [PMID: 31191551 DOI: 10.3389/fimmu.2019.01193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Tsokos GC. Double-negative T cells in autoimmune diseases. Curr Opin Rheumatol 2021;33:163-72. [PMID: 33394752 DOI: 10.1097/BOR.0000000000000778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Seyrek K, Ivanisenko NV, Wohlfromm F, Espe J, Lavrik IN. Impact of human CD95 mutations on cell death and autoimmunity: a model. Trends Immunol 2022;43:22-40. [PMID: 34872845 DOI: 10.1016/j.it.2021.11.006] [Reference Citation Analysis]
3 Consonni F, Gambineri E, Favre C. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies. Ann Hematol. [DOI: 10.1007/s00277-022-04761-7] [Reference Citation Analysis]
4 Sama S, Challa A, Patel FV, Saineni S, Erpenwar S, Maryala S. Idiopathic CD4+ Lymphocytopenia Due to Homozygous Loss of the CD4 Start Codon. Cureus 2021;13:e15251. [PMID: 34188990 DOI: 10.7759/cureus.15251] [Reference Citation Analysis]
5 Campos JS, Henrickson SE, Abraham RS. Expanding mechanistic insights into the pathogenesis of idiopathic CD4+ T cell lymphocytopenia. J Clin Invest 2020;130:5105-8. [PMID: 32865518 DOI: 10.1172/JCI141717] [Reference Citation Analysis]
6 Perez-Diez A, Wong CS, Liu X, Mystakelis H, Song J, Lu Y, Sheikh V, Bourgeois JS, Lisco A, Laidlaw E, Cudrici C, Zhu C, Li QZ, Freeman AF, Williamson PR, Anderson M, Roby G, Tsang JS, Siegel R, Sereti I. Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia. J Clin Invest 2020;130:5326-37. [PMID: 32634122 DOI: 10.1172/JCI136254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Cudrici CD, Boulougoura A, Sheikh V, Freeman A, Sortino O, Katz JD, Sereti I, Siegel RM. Characterization of autoantibodies, immunophenotype and autoimmune disease in a prospective cohort of patients with idiopathic CD4 lymphocytopenia. Clin Immunol 2021;224:108664. [PMID: 33422677 DOI: 10.1016/j.clim.2021.108664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Michalak SS, Olewicz-Gawlik A, Rupa-Matysek J, Wolny-Rokicka E, Nowakowska E, Gil L. Autoimmune hemolytic anemia: current knowledge and perspectives. Immun Ageing 2020;17:38. [PMID: 33292368 DOI: 10.1186/s12979-020-00208-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang C, Walter JE. Autoantibodies in immunodeficiency syndromes: The Janus faces of immune dysregulation. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100948] [Reference Citation Analysis]
10 Lambert MP. Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS). Expert Rev Clin Immunol 2021;17:1163-73. [PMID: 34503378 DOI: 10.1080/1744666X.2021.1978842] [Reference Citation Analysis]
11 Hafezi N, Zaki-Dizaji M, Nirouei M, Asadi G, Sharifinejad N, Jamee M, Erfan Rasouli S, Hamedifar H, Sabzevari A, Chavoshzadeh Z, Yazdani R, Abolhassani H, Aghamohammadi A, Azizi G. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review. Pediatr Allergy Immunol 2021. [PMID: 33963613 DOI: 10.1111/pai.13535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]